Open science, COVID-19, and the news: Exploring controversies in the circulation of early SARS-CoV-2 genomic epidemiology research.

Molecular epidemiology media studies pathogen genomics science and technology studies science communication

Journal

Global public health
ISSN: 1744-1706
Titre abrégé: Glob Public Health
Pays: England
ID NLM: 101256323

Informations de publication

Date de publication:
Historique:
pubmed: 5 3 2021
medline: 19 8 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

Some early English language news coverage of COVID-19 epidemiology focused on studies that examined how SARS-CoV-2 (the coronavirus that causes COVID-19) was evolving at the genetic level. The use of phylogenetic methods to analyse pathogen genetic sequence data to understand disease dynamics is called 'molecular' or 'genomic' epidemiology. Many research groups in this subfield utilise open science practices, which can involve the circulation of early unreviewed findings on publicly-accessible venues online. From March to May 2020, media outlets covered early SARS-CoV-2 genomic studies that claimed to have discovered types of SARS-CoV-2 that had mutated to be more transmissible. We use methods from Science and Technology Studies (STS) to examine three cumulative cases in which unripe facts about SARS-CoV-2 genomics moved out of scientific publics and into mainstream news. The three cases are: (1) 'A More "Aggressive" Strain of SARS-CoV-2?', (2) 'Eight SARS-CoV-2 Strains?', and (3) 'A "More Contagious," "Mutant" Strain?' In each case, findings were called into question and reporters' framing was overly sensational. We interpret the COVID-19 pandemic as a 'stress-test' for open science practices, and argue that it is important for stakeholders to understand changes in scientific publication and dissemination processes in the wake of the pandemic.

Identifiants

pubmed: 33661076
doi: 10.1080/17441692.2021.1896766
pmc: PMC8338786
mid: NIHMS1687840
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1468-1481

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR001415
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001414
Pays : United States

Références

Geo. 2015 Jun 30;2(1):12-16
pubmed: 26435842
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Virus Evol. 2020 May 14;6(1):veaa034
pubmed: 32817804
Glob Public Health. 2018 Sep;13(9):1158-1168
pubmed: 28594309
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
J Med Virol. 2020 Sep;92(9):1386-1390
pubmed: 32311094
Lancet Glob Health. 2020 May;8(5):e627-e630
pubmed: 32220289
Microb Genom. 2019 Apr;5(4):
pubmed: 30938670
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Soc Stud Sci. 2018 Feb;48(1):165-167
pubmed: 29380673
Health Place. 2012 Jul;18(4):710-7
pubmed: 21470893
J Clin Epidemiol. 2014 Oct;67(10):1103-10
pubmed: 25034197
Nature. 2018 Jul;559(7715):445
pubmed: 30042547
Nature. 2020 Jun;582(7811):167-168
pubmed: 32504015
J Infect Dis. 2007 May 1;195(9):1250-9
pubmed: 17396993
Soc Stud Sci. 2018 Apr;48(2):171-203
pubmed: 29726809
Neuron. 2016 Nov 2;92(3):612-616
pubmed: 27810003
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
N Engl J Med. 2019 Dec 26;381(26):2569-2580
pubmed: 31881145
Soc Stud Sci. 2016 Aug;46(4):586-606
pubmed: 28948871
Nat Chem. 2020 Jun;12(6):499-502
pubmed: 32424256
Med Soc (Berkeley). 1996;:1-466
pubmed: 11619509
J Med Ethics. 2011 Nov;37(11):688-92
pubmed: 21586404
JAMA. 2021 Feb 9;325(6):529-531
pubmed: 33404586
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002
Am J Bioeth. 2020 Oct;20(10):10-23
pubmed: 32945756

Auteurs

Stephen Molldrem (S)

Department of Anthropology, University of California, Irvine, CA, USA.

Mustafa I Hussain (MI)

Department of Informatics, University of California, Irvine, CA, USA.

Anthony K J Smith (AKJ)

Centre for Social Research in Health, UNSW Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH